Vincent Caggiano

Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

Katrina Bauer, Monica Brown, Rosemary D. Cress et al. · Cancer · 2007 · 2.1K citations

Medicine, Oncology, Breast Oncology +11

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

Vincent Caggiano, Richard V. Weiss, Timothy S. Rickert et al. · Cancer · 2005 · 330 citations

Medicine, Oncology, Cancer Epidemiology +10

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

Carol Parise, Katrina Bauer, Monica Brown et al. · The Breast Journal · 2009 · 329 citations

Medicine, Biostatistics, Oncology +13

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

Bernard Fisher, Stewart Anderson, D. Lawrence Wickerham et al. · Journal of Clinical Oncology · 1997 · 311 citations

Medicine, Oncology, Pharmacotherapy +17

Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

Carol Parise, Vincent Caggiano · Journal of Cancer Epidemiology · 2014 · 265 citations · Full text

Medicine, Oncology, Pathology +17